Abiopharma

OmniAb Announces $30 Million Private Placement

Novocure Announces Coverage of Tumor Treating Fields (TTFields) Therapy for Patients with Newly Diagnosed Glioblastoma in Spain

Sharps Technology, Inc. Announces over $400 Million Private Placement seeking to Establish the Largest Solana Digital Asset Treasury Strategy

OmniAb Announces $30 Million Private Placement

New Evidence Published Supporting Use of DecisionDx®-SCC Test in Guiding and Improving Treatment Pathway Decisions in NCCN High-Risk Cutaneous Squamous Cell Carcinoma

Bristol Myers Squibb - Bristol Myers Squibb to Present New Clinical and Real-World Data at the European Society of Cardiology Congress 2025

Bristol Myers Squibb to Present New Clinical and Real-World Data at the European Society of Cardiology Congress 2025

Bristol Myers Squibb to Present New Clinical and Real-World Data at the European Society of Cardiology Congress 2025

Merck Demonstrates Ongoing Commitment to Advancing Cardiovascular Disease Management and Patient Care with New Data at the European Society of Cardiology Congress 2025

New Form 8-K - Axogen, Inc. Filed: 2025-08-25 AccNo: 0000805928-25-000112 Size: 203 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Axogen Provides Update on FDA Review Timeline for Avance Nerve Graft

New Form 8-K - BeOne Medicines Ltd. Filed: 2025-08-25 AccNo: 0001628280-25-041082 Size: 248 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements …

New Form 6-K - Valneva SE Filed: 2025-08-25 AccNo: 0001836564-25-000011 Size: 41 KB

New Form 6-K - HUTCHMED Filed: 2025-08-25 AccNo: 0001648257-25-000057 Size: 82 KB

Royalty Pharma to Acquire Royalty Interest inAmgen’s Imdelltra for up to $950 Million